Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
11/2003
11/13/2003US20030212117 Efficient process for the preparation of a factor Xa inhibitor
11/13/2003US20030212026 Induce immunology response
11/13/2003US20030212009 Isoflavone derivatives
11/13/2003US20030211167 Aqueous solution of amylopectin starch and drugs; injectable
11/13/2003US20030211080 Congestive heart failure; monitoring gene expression; supplying adeno-associated viral vector
11/13/2003US20030211050 Compositions comprising anionic functionalized polyorganosiloxanes for hydrophobically modifying surfaces and enhancing delivery of active agents to surfaces treated therewith
11/13/2003CA2483660A1 Injectable chondrocyte implant
11/13/2003CA2483653A1 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-utr of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4
11/12/2003EP1360187A1 3,7-diazabicyclo(3.3.0)octanes and their use in the treatment of cardiac arrhythmias
11/12/2003EP1359925A1 A method to enhance the immune system and used for the prevention and treatment of asthma
11/12/2003EP0975599B1 Subtituted isoquinolines as ultra short acting neuromuscular blockers
11/12/2003CN1455873A MRI method involving the use of a hyperpolarized contrast agent
11/12/2003CN1455681A Contraception process and administration for same
11/12/2003CN1127510C Prodrugs of thrombin inhibitors
11/12/2003CN1127477C Methods and compositions for lipidization of hydrophilic molecules
11/12/2003CN1127350C Cyclosorin-containing soft capsule preparations
11/12/2003CN1127336C Remedy for pulmonary heart
11/11/2003US6647358 Pharmacokinetic-based drug design tool and method
11/11/2003US6645977 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ACh receptors
11/11/2003US6645967 Arylpiperazines having activity at the serotonin 1A receptor
11/11/2003US6645492 For diagnosis and therapy of susceptibility to atopic allergy, asthma
11/11/2003US6645466 Dry powder for inhalation
11/11/2003CA2039456C Osmotic dosage system for liquid drug delivery
11/06/2003WO2003091717A1 Systems and methods for blood glucose sensing
11/06/2003WO2003090692A2 Make-up applicator with led light source
11/06/2003WO2003090683A2 Mixing device for surgical sealants, and method thereof
11/06/2003WO2003090666A2 Glucocorticoid receptor protein crystals
11/06/2003WO2003020218A3 Salvianolic acid b
11/06/2003WO2003013428A3 Nutritional supplements and methods of using same
11/06/2003WO2002076375A3 Process for the preparation of benazepril
11/06/2003WO2002018369A8 Peptidomimetic protease inhibitors
11/06/2003US20030208079 Heterocyclic amines such as (2S,3S)-3-((1R)-6-methoxy-1-methyl -1-trifluoromethylisochroman-7-yl)methylamino-2-phenyl piperidine, used as analgesics, antiinflammatory agents, or for proph7ylaxis of cardiovascular disorders
11/06/2003US20030208045 Binds to Osteoclastogenesis Inhibitory Factor (OCIF) binding molecule (OBM)
11/06/2003US20030207920 N-(heterocyclyl)benzene or pyridinesulphonamides as antithrombotic agents and anticoagulants
11/06/2003US20030207836 Ovo nucleotide immuno-stimulant. The VAF contains one or more DNA constructs, each having a DNA molecule and a vector. Each of the DNA molecule contains one or more genes or gene fragments, each encoding an antigenic peptide of an avian
11/06/2003US20030206974 Antiviral substances from plant cuticular and epicuticular material
11/06/2003US20030206956 Topical treatment of prevention of ocular infections
11/06/2003US20030206949 Dispersible phospholipid stabilized microparticles
11/06/2003US20030206932 Stable skin care compositions comprising an oil-in-water emulsion and certain retinoids
11/06/2003US20030206906 Water, a plasminogen activator, and a bacteriostatic organic alcohol preservative; does not contain a chelating agent; removal of fibrin-bound blood clots from a catheter
11/05/2003EP1359159A2 Analogues of GLP-1
11/05/2003EP1358213A2 Humanized antibodies that recognize beta amyloid peptide
11/05/2003EP1268468B1 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline mesylat and polymorphs
11/05/2003EP0994713B1 USE OF A 7alpha-METHYL-17alpha-ETHYNYL-ESTRANE DERIVATIVE FOR THE TREATMENT OF ATHEROSCLEROSIS
11/05/2003EP0956854B1 Pharmaceutical composition comprising coenzyme q 10
11/05/2003EP0699073B1 xenogeneic transplantation
11/05/2003CN1454096A Activity of extract of piper betle leaves against leishmania
11/05/2003CN1454095A A pharmaceutical composition for treating headache disease and process and uses thereof
11/05/2003CN1454091A Immunostimulatory nucleic acids
11/05/2003CN1126546C Reduction of infarction region using citicoline
11/04/2003US6642266 EP4 receptor selective agonists in the treatment of osteoporosis
11/04/2003US6642247 Treting anxiety, stress, depression, trauma, Alzheimer's mediated memory loss, epilepsy, arterial blood pressure disorders, obesity, acute pain, chronic pain, Na+ excretion, control of water balance, and symptoms associated with drug
11/04/2003US6642222 Pyrano, piperidino, and thiopyrano compounds and methods of use
11/04/2003US6641849 Mixture of L-carnitine, acetyl L-carnitine, and propionyl L-carnitine or salts; cardiovascular, gastrointestinal, sleep, nervous system, and nervous system disorders
11/04/2003US6641800 Administration by inhalation comprising a liquefied hydrofluoroalkane, a powdered medicament dispersed therein, and a suspending agent comprising a polymer soluble in the liquefied hydrofluoroalkane which is selected from polymers
11/04/2003US6641618 Ready-to-use aqueous composition for bleaching keratin fibers, comprising a combination of a water-soluble solvent and a nonionic and/or anionic amphiphilic polymer comprising at least one fatty chain
11/04/2003CA2188283C Substituted 1,3-oxathiolanes with antiviral properties
10/2003
10/30/2003WO2003089411A1 Derivatives of n-[phenyl(piperidin-2-yl)methyl]benzamide, the preparation method thereof and application of same in therapeutics
10/30/2003WO2003088920A2 Low profile combination device for gastrostomy or jejunostomy applications having anti-granuloma formation characteristics
10/30/2003WO2003088909A2 Methods for modulating phototoxicity
10/30/2003WO2003088899A2 Methods for the production of chimeric adeno-associated virus (aav) vectors, compositions of chimeric aav vectors, and methods of use thereof
10/30/2003WO2003045319A3 Targeted therapeutics and uses thereof
10/30/2003WO2003028527A3 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof
10/30/2003WO2003011228A3 Purification and crystalline forms of zaleplon
10/30/2003US20030204090 Administering to a patient an indazoline compound to treat cancer, inflammatory disorder or autoimmune disease
10/30/2003US20030203930 Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
10/30/2003US20030203876 Comprises epothilone in form of infusion concentrate or lyophilised composition
10/30/2003US20030203839 Iron binding protein lactoferrin as a medicament to prevent the progression of systemic inflammatory response syndrome (SIRS) into sepsis, septic shock and multiple organ failure in mammal
10/29/2003EP1356024A2 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods
10/29/2003EP1355907A1 Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes
10/29/2003EP1355905A1 Pyrazole compounds useful as protein kinase inhibitors
10/29/2003EP1355884A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes
10/29/2003EP1235787B1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS
10/29/2003EP1204663B1 Novel spiro compounds with neuropeptide y antagonistic activity
10/29/2003EP0957898B1 Personal wash liquid composition comprising low viscosity oils pre-thickened by non-antifoaming hydrophobic polymers
10/29/2003CN1452479A Stable pharmaceutical solution formulations for pressurised metered dose inhalers
10/29/2003CN1451656A Novel salt of perindopril and pharmaceutical composition contg. same
10/29/2003CN1125877C Hepatitis G. Virus and molecular cloning thereof
10/28/2003US6639074 Reacting an alpha -substituted ketone with a cyclic alkylenetetramine in solvent(s) to form a quaternary ammonium salt; reacting with acid in solvent(s) form an alpha -amino ketone; reacting with acyl derivative; dehydrating
10/28/2003US6638969 Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications
10/28/2003US6638934 2,3,4,4a,5,6-hexahydro-1H-pyrazino(1,2-a)quinoxaline derivatives; treating depression, schizophrenia; (5-hydroxytryptamine=5HT) 5HT2a antagonist or a 5HT2c agonist
10/28/2003US6638931 Aminoguanidines and alkoxyguanidines as protease inhibitors
10/28/2003US6638540 Plant extracts for the treatment of increased bone resorption
10/28/2003US6638525 Pharmaceuticals, dietary supplements and cosmetic compositions, and the use of certain mixtures for preparing a medicament or a dietary supplement for the treatment or prevention of inflammation, hypersensitivity reactions or pain
10/23/2003WO2003087371A1 Antiviral therapy on the basis of rna interference
10/23/2003WO2003087050A2 Novel perindopril salt and pharmaceutical compositions containing same
10/23/2003WO2003086459A1 Methods of treatement using ctla-4 antibodies
10/23/2003WO2003086351A1 Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease
10/23/2003WO2003086322A2 Low power laser therapy control
10/23/2003WO2003086313A2 Methods for lightening skin and hair
10/23/2003WO2003086297A2 Multi-layer mucoadhesive drug delivery device with bursting release layer
10/23/2003US20030199568 Salt of perindopril and pharmaceutical compositions containing it
10/23/2003US20030199559 Process for making amlodipine maleate
10/23/2003US20030199493 A dibenzofuranazepine derivatives for use as therapeutic treatment of Alzheimer's disease, Parkinson's disease, Huntington's disease, multiple sclerosis, amyotrophic lateral sclerosis, epilepsy, stroke, cerebral trauma
10/23/2003US20030198959 Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases
10/23/2003CA2482395A1 Antiviral therapy on the basis of rna interference
10/23/2003CA2481784A1 Methods for lightening skin and hair
10/23/2003CA2481207A1 Methods of treatment using ctla-4 antibodies
10/23/2003CA2480763A1 Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease
10/22/2003EP1354878A2 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors
1 ... 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 ... 295